Publikációk idegen nyelven


Muszbek, L., Hauck, M.: Fragmentation of actin by thrombin-like snake venom proteases. Biochim. Biophys. Acta 577, 34-43 (1979)

Muszbek, L.: Biochemical mechanism of platelet activation. Involvement of contractile proteins. Folia Haematol. 106, 765-775 (1979)



Hársfalvi, J., Muszbek, L., Stadler, I., Fésüs, L.: Inhibition of platelet factor 3 availability by prostacyclin. Prostaglandins  20, 935-936 (1980)

 Jelenska, M.M., Fésüs, L., Kopec, M.: The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate. Biochim. Biophys. Acta 616, 4061-4066 (1980)



Fésüs, L., Hársfalvi, J., Kovács, E., Muszbek, L., Stadler, I.: Effect of prostaglandin I2 on platelet adhesion. Biomaterials 2, 53-54 (1981)

Fésüs, L., Muszbek, L., Laki, K.: The effect of methylglyoxal on actin. Biochem. Biophys. Res. Commun. 99, 617-622 (1981)

Fésüs, L., Jelenska, M.M., Kopec, M.: Degradation by thrombin of denatured collagen and of collagenase digestion products. Thromb. Res. 22, 367-373 (1981)

Fésüs, L., Sándor, M., Horváth, L.I., Bagyinka, Cs., Erdei, A., Gergely, J.: Immune-complex-induced transglutaminase activation: its role in the Fc-receptor-mediated transmembrane effect on peritoneal macrophages. Mol. Immunol. 18(7), 633-638 (1981)

Fésüs, L., Falus, A., Erdei, A., Laki, K.: Human ß2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface.  J. Cell Biol. 89, 706-710 (1981)



Fésüs, L.: Transglutaminase activation: Significance with respect to immunologic phenomena. Surv. Immunol. Res. 1(4), 297-304 (1982)

Fésüs, L., Erdei, A., Sándor, M., Gergely, J.: The influence of tissue transglutaminase on the function of Fc receptors. Mol. Immun. 19(1) 39-43 (1982)



Fésüs, L., Horváth, A., Hársfalvi, J.: Interaction between tissue transglutaminase and phospholipid vesicles. FEBS Letters 155(1) 1-5 (1983)

Sándor, M., Erdei, A., Fésüs, L., Gergely, J.: IgG-Fc receptors differ in sensitivity to primary amines. Immun. Letters 6, 265-269 (1983)



Koteliansky, V. E., Gneushev, G.N., Glukhova, M.A., Venyaminov, S.Y., Muszbek, L.: Identification and isolation of vinculin from platelets. FEBS Lett. 165, 26-30 (1984)

Fésüs, L., Hársfalvi, J., Horváth, A., Sándor, M.: Transglutaminase and receptor signaling: concepts and realities. Mol. Immun. 21(12), 1161-1165 (1984)

Kávai, M., Berényi, E., Zsindely, A., Szegedi, Gy., Fésüs, L.: Monocyte activation in patients with Hodgkin’s disease. Int. J. Cancer 34, 483-485 (1984)



Muszbek, L., Polgár, J., Fésüs, L.: Kinetic determination of blood coagulation Factor XIII in plasma. Clin. Chem. 31, 35-40 (1985)

Muszbek, L., Ádány, R., Szegedi, G., Polgár, J., Kávai, M.: Factor XIII of blood coagulation in human monocytes. Thromb. Res. 37, 401-410 (1985)

Ádány, R., Belkin, A., Vasilevskaya, T., Muszbek, L.: Identification of blood coagulation Factor XIII in human peritoneal macrophages. Eur. J. Cell. Biol. 38, 171-173 (1985)



Fésüs, L., Metsis, M.L., Muszbek, L., Koteliansky, V.E.: Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. Eur. J. Biochem. 154, 371-374 (1986)

Fésüs, L., Arató, G.: Quantitation of tissue transglutaminase by a sandwich ELISA system. J. Immunol. Methods  94, 131-136 (1986)

Lee, K.N., Birckbichler, P.J., Fésüs, L.: Purification of human erythrocyte transglutaminase by immunoaffinity chromatography. Preparative Biochem.  16, 321-335 (1986)

Berényi, E., Zsindely, A., Fésüs, L., Szegedi, Gy., Kávai, M.: Acid phosphatase activity in monocytes and sera of patients with Hodgkin disease. Cancer Letters 32, 219-222 (1986)

Polgár, J., Léránt, I., Muszbek, L., Machovich, R.: Thrombomodulin inhibits the activation of factor XIII by thrombin. Thromb. Res. 43, 585-590 (1986)

Nemes, Z., Thomázy, V., Ádány, R., Muszbek, L.: Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (FXIIIa) in human lymph nodes. J. Pathol. 149, 121-132 (1986)



Asijee, G.M., Sturk, A., Muszbek, L.: Association of vinculin to the platelet cytoskeleton during thrombin-induced aggregation. Exp. Cell Res. 168, 358-364 (1987)

Ádány, R., Nemes, Z., Muszbek, L.: Characterization of Factor XIII containing macrophages in lymph nodes with Hodgkin’s disease. Brit. J. Cancer 55, 421-426 (1987)

Hársfalvi, J., Arató G., Fésüs, L.: Lipids associated with tissue transglutaminase. Biochim. Biophys. Acta 923, 42-45 (1987)

Muszbek, L., Ádány, R., Glukhova, M.A., Frid, M.G., Kabakov, A.E., Koteliansky, V.E.: The identification of vimentin in human blood platelets. Eur. J. Cell. Biol.  43, 501-504 (1987)

Glukhova, M.A., Ornatsky, O.I., Frid, M.G., Kabakov, A.E., Ádány, R., Muszbek, L., Smirnov, V.N.: Identification of smooth muscle derived foam cells in the atherosclerotic plaque of human aorta with monoclonal antibody IIG1O. Tissue and Cell 19, 657-663 (1987)

Ádány, R., Kiss, A., Muszbek, L.: Factor XIII: a marker of mono-and megakariocytopoesis. Br. J. Haematol. 67, 167-172, (1987)

Ádány, R., Muszbek, L.: Cells containing Factor XIII subunit a in benign and malignant soft tissue tumours. Histopathology 11, 1341-1343, (1987)

Nemes, Z., Ádány, R., Thomázy, V.: Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by the immunohistochemical demonstration of the subunit A of factor XIII (F-XIIIa). Virchows Arch. (Cell Pathol.) 52, 453-466 (1987)

Ádány, R., Kappelmayer J., Muszbek L.: Expression of factor XIII subunit A in different types of human macrophages. In: The biology of phagocytes in health and disease. Advances in Biosciences 66:323-333, 1987. eds. Mauri C, Rizzo Sc, Ricevuti G



Ádány, R., Glukhova, A.M., Kabakov, A.Y., Muszbek, L.: Characterization of human connective tissue cells containing factor XIII subunit a J. Clin. Pathol. 41, 49-56 (1988)

Muszbek, L., Ádány, R., Kávai, M., Boda, Z., Lopaciuk, S.: Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity. Thromb. Haemost. 59, 231-235, (1988)

Asijee, G.M., Muszbek, L., Kappelmayer, J., Polgár, J., Horváth, A., Sturk, A.: Platelet vinculin: a substrate of activated Factor XIII. Biochim. Biophys. Acta 954, 303-308 (1988)

Ádány, R., Szegedi, A., Ablin, R.J., Muszbek, L.: Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin’s disease. Thromb. Haemost. 60,  293-297 (1988)

Ádány, R.: Identification of Factor XIIIa in cutaneous tissue. Histopathology 13, 363-364 (1988)

Módis, L., Lustyik, Gy., Ádány, R., Zs.-Nagy, I.: Energy dispersive X-ray microanalysis of sulphated glycosaminoglycans in cartilage matrix stained with Alcian Blue 8GX. Bas. Appl. Histochem. 32, 415-428 (1988)

Módis, L., Matesz, C., Telek, B., Ádány, R.: Submicroscopic structure of glycosaminoglycans in osteocyte capsule of human embryonic bone as revealed by polarization microscopy. Arch. Ital. Anat. Embriol. 94, 283-288 (1989)



Ádány, R., Muszbek, L.: Immunohistochemical detection of Factor XIII subunit a in histiocytes of human uterus. Histochemistry 91, 169-174 (1989)

Muszbek, L., Laposata, M.: Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J. Biol. Chem. 264, 9716-9719 (1989)

Muszbek, L., Laposata, M.: Covalent modification of platelet proteins by palmitate. Blood 74, 1339-1347 (1989)

Polgár, K., Ádány, R., Ábel, G., Kappelmayer, J., Muszbek, L., Papp Z.: Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescent and phagocytosis assays. Am. J. Hum. Genet. 45, 786-792 (1989)

Boda, Z., Pfliegler, G., Muszbek, L., Tóth, A., Ádány, R., Hársfalvi, J., Papp, Z., Tornai, I., Rák, K.: Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. Haemostasis 19, 348-352 (1989)

Ádány, R., Kappelmayer, J., Berényi, E., Szegedi, A., Fábián, E., Muszbek, L.: Factors of the extrinsic pathway of blood coagulation in tumor associated macrophages. Thromb. Haemost. 62, 850-855 (1989)

Ádány, R.: Detection of platelets in routinely processed specimens. Histopathology 15, 316 (1989)

Boján, F., Kávai, M., Ádány, R., Pásti, G., Nemes, Z., Sipos, A., Takács, I., Ács, G., Muszbek, L., Szegedi, G.: Establishment of a new human myelomonocytic leukaemia cell line (DD) and its functional activation by 12-O-tetradecanoylphorbol 13-acetate (TPA) and lipopolysaccharide (LPS). Cytotechnology  S 31-33 (1989)

Kappelmayer, J., Ádány, R.: Factors of the extrinsic pathway of blood coagulation in fetal placental macrophages. Am. J. Repr. Immunol. 21, 37-40 (1989)

Kiss, A., Pecze, K., Iványi, J.L., Telek, B., Ádány, R., Rák, K.: Die Diagnostik der megakaryoblastischen Leukämie. Folia Haematol. 116, 37-41 (1989)



Ádány, R., Fodor, F., Molnár, P., Muszbek, L.: Increased density of histiocytes in uterine leiomyomas. Int. J. Gynec. Pathol. 9, 137-144 (1990)

Polgár, J., Hidasi, V., Muszbek, L.: Nonproteolytic activation of cellular protransglutaminase (placenta macrophage Factor XIII). Biochem. J. 267, 557-56O (1990)

Ádány, R., Iozzo, R.: Altered methylation of versican proteoglycan gene in human colon carcinoma. Biochem. Biophys. Res. Commun. 171, 1402-1413 (1990)

Ádány, R., Heimer, R., Caterson, B., Sorell, J.M., Iozzo, R.V.: Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem. 265, 11389-11396 (1990)

Horváth, A.R., Elmore, M.A., Kellie, S.: Differential tyrosine-specific phosphorylation of integrin in Rous sarcoma virus transformed cells with differing transformed phenotypes. Oncogene 5, 1349-1357 (1990)

Horváth, A.R., Kellie, S.: Regulation of integrin mobility and cytoskeletal association in normal and RSV-transformed chick embryo fibroblasts. J. Cell Sci. 97, 307-315 (1990)

Felice, G., Horváth, A.R., Kellie, S.: Tyrosine kinase activities and neoplastic transformation. Biochem. Soc. Transact. 18, 69-72 (1990)

Elmore, M.A., Anand, R., Horváth, A.R., Kellie, S.: Tyrosine-specific phosphorylation of gpIIIa in platelet membranes. FEBS Letters 269(2), 283-287 (1990)

Ablin, R.J., Bartkus, J.M., Polgár, J.: Effect of human seminal plasma on the lytic activity of natural killer cells and presumptive identification of participant macromolecules. Am. J. Repr. Immunol.  24, 15-21 (1990)



Szabó, E., Muszbek, L.: Isolation and partial characterization of a cystin-rich basic heparin-binding protein from bovine platelets. Biochem. Biophys. Res. Commun. 174, 70-76 (1991)

Kellie, S., Horváth, A.R., Elmore, M.A.: Cytoskeletal targets for oncogenic tyrosine kinases. J. Cell Sci. 99, 207-211 (1991)

Horváth, A.R., Kiss, Zs., Anand, R., Kellie, S.: Association of pp60c-src with the cytoskeleton upon platelet activation. Biochem. Soc. Transact. 19, 1150-1154 (1991)

Zeher, M., Ádány, R., Nagy, G., Gomez, R., Szegedi, Gy.: Macrophages containing FXIII A in minor labial  salivary gland biopsy from patients with primary Sjögren’s syndrome. J. Invest. Allergol. Clin. Immunol. 1, 261-265 (1991)

Ádány, R., Iozzo, V.: Hypomethylation of decorin proteoglycan gene in human colon cancer. Biochem. J. 276, 301-306 (1991)



Kávai, M., Ádány, R., Pásti, G., Surányi, P., Szücs, G., Muszbek, L., Boján, F., Szegedi, Gy.: Marker profile, enzyme activity and function of a human myelomonocytic leukaemia cell line. Cell. Immunol. 139, 531-540 (1992)

Horváth, A.R., Asijee, G.M., Muszbek, L.: Cytoskeletal assembly and vinculin-cytoskeleton interaction in different phases of the activation of bovine platelets. Cell. Motil. Cytoskeleton 21, 123-131 (1992)

Horváth, A.R., Muszbek, L., Kellie, S.: Translocation of pp60c-src to the cytoskeleton during platelet aggregation. EMBO J. 11, 855-861 (1992)



Muszbek, L., Polgár, J., Boda, Z.: Platelet Factor XIII becomes active without the release of activation peptide during platelet activation. Thromb. Haemost. 69,  282-285 (1993)

Muszbek, L., Laposata, M.: Myristoylation of protein in platelets occurs predominantly through thioester linkages. J. Biol. Chem.  268, 8251-8255 (l993)

Muszbek, L., Laposata, M.: Covalent modification of proteins by arachidonate and eicosapentaenoate in platelets. J. Biol. Chem. 268, 18243-18248 (1993)

Fujimoto, T., Stroud, E., Whatley, R. E., Prescott, S. M., Muszbek, L., Laposata, M., McEver, R. P.: P-selectin is acylated with palmitic acid and stearic acid at cysteine 766 through a thioester linkage . J. Biol. Chem.  268, 11394-11400  (1993)

Ádány, R.: Janus-faced tumor associated macrophages. Immunol. Today 14, 142-143 (1993)

Ádány, R.,  Toida, M., Takami, T.: Arborizing tenascin network under the rapidly proliferating epithelium of epulis. J. Histochem. Cytochem. 41, 1717-1718 (1993)

Kappelmayer, J.,  Kunapuli, S.P., Wyshock, E.G., Colman, R.W.: Characterization of monocyte associated factor V. Thromb. Haemost. 70(2), 273-280 (1993)

Kappelmayer, J., Bernabei, A., Edmunds, L.H.: Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ. Res. 72, 1075-1081 (1993)

Góth, L., Alizadeh, B.N., Sussman, H.H.: Further characterization of Hungarian acatalasemia by Hinf1 polymorphism of catalase gene. Enzyme Protein 47, 156-159 (1993)

Kappelmayer, J., Bernabei, A., Gikakis, N., Edmunds, L.H., Colman, R.W.: Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J. Lab. Clin. Med. 121, 118-126 (1993)

Polgár, J., Clemetson, J.M., Gengenbacher, D., Clemetson, K.J.: Additional GPI-anchored glycoproteins on human platelets that are absent or deficient in paroxysmal nocturnal haemosglobinuria.FEBS Letters 327, 49-53 (1993)



Hallak, H., Muszbek, L., Laposata, M. Belmonte, E., Brass, L. F. and Manning, D. R.  Covalent  binding of arachidonate to G protein  α subunits of human platelets. J. Biol. Chem.  269, 4713-4716 (1994)

Matesz, C., Birinyi, A., Hevessy, Zs.: Motoneurons differ in size and peripheral target in the trigeminal and facial nuclear complex of the  frog. J. Brain Res.  35 (1), 67-70 (1994)

Molnár, Cs., Hevessy, Zs., Rozgonyi, F., Gemmell, C.G.: Pathogenicity and virulence of coalugase-negative staphylococci (CNS) in relation to adherence, hydrophobicity and toxin production in vitro. J. Clin. Pathol. 47, 743-748 (1994)

Kappelmayer, J.,  Bacskó, Gy., Kelemen, E., Ádány, R.: Onset and distribution of factor XIII containing cells in the mesenchyme of chorionic villi during early phase of human placentation. Placenta 15, 613-623 (1994)

Zeher, M., Szegedi, Gy., Csiki, Z., Cseh, A., Ádány, R.: Fibrinolysis resistant fibrin deposits in minor labial salivary glands of patients with Sjögren’s syndrome. Clin. Immunol. Immunopathol. 71, 149-155 (1994)

Hársfalvi, J., Tarcsa, E., Udvardy, M., Fésüs, L.: Enzymatic fluorimetric assay for g(g-Glutamyl) lysine isodipeptides. Fibrinolysis 8, 378-381 (1994)



Muszbek, L., Haramura, G., Polgár, J.: Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb. Haemost. 73, 702-705 (1995)

Hidasi, V., Muszbek, L.: Transglutaminase activity in normal human lenses and in senile cataracts. Ann. Clin. Lab. Sci. 25, 236-240 (1995)

Hidasi, V., Ádány, R., Muszbek, L.: Localization of transglutaminase in human lenses. J. Histochem. Cytochem. 43, 1173-1177 (1995)

Góth, L., Vitai, M.: Hungarian hereditary acatalasemia and hypocatalasemia are not associated with chronic hemolysis.  Clin. Chim. Acta 233, 75-79 (1995)

Kappelmayer, J., Bacskó, Gy., Birinyi, L., Zákány, R., Kelemen, E., Ádány, R.: Consecutive appearance of factor XIII subunit A in macrophages, megakaryocytes and liver cells in early human development. Blood 86, 2191-2197 (1995)

Pixley, R.A., Zellis, S., Bankes, P., de laCadena, R.A., Page, J.D., Scott, C.F., Kappelmayer, J., Wyshock, E.G., Kelly, J.J., Colman, R.W.: The prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit. Care Med. 23, 41-51 (1995)

Hársfalvi, J., Stassen, J.M., Van Houtte, E., Sawyer, R.T., Vermylen, J., Deckmyn, H.: Calin from Hirudo Medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 85, 705-711 (1995)



Muszbek, L., Ádány, R., Mikkola, H.: Novel aspects of blood coagulation Factor XIII. I. Structure, distribution, activation and function. Crit. Rev.  Clin. Lab. Sci. 33,  357-421 (1996)

Hevessy, Zs., Haramura, G., Boda, Z., Udvardy, M., Muszbek, L.: Promotion of the crosslinking of fibrin and α2-antiplasmin by platelets. Thromb. Haemost. 75, 161-167 (1996)

Laposata, M., Muszbek, L.: Thioesterification of platelet proteins with saturated and polyunsaturated fatty acids. Lipids  31, 217-221 (1996)

Seitz, R., Duckert, F., Lopaciuk, S., Muszbek, L., Rodeghiero, F., Seligsohn, U.: ETRO Working Party on factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Sem. Thromb. Hemost. 22, 415-418 (1996)

Góth, L., Páy, A.: Genetic heterogeneity in acatalasemia. Electrophoresis 17, 1302-1303 (1996)

Góth, L.,  Vitai, M.: Hypocatalasemia in hospital patients. Clin.Chem. 42, 341-342 (1996)

Udvardy, M., Pósán, E., Hársfalvi, J., Dinya, Z.: New pentamidine related substances which simultaneously inhibit platelet aggregation and plasmin generation and in vitro clot lysis. Blood. Coag. Fibrinol. 7, 256-258 (1996)

Kozma, L., Lenkey, Á., Varga, É., Gomba, Sz.: Induction of renin release from isolated glomeruli by inorganic mercury(II). Toxicology Letters 85, 49-54 (1996)



Van Cott, E.M.,  Muszbek, L., Laposata, M.: Fatty acid acylation of platelet proteins. Prostaglandins, Leukotrienes and Essential Fatty Acids  57, 33-37 (1997)

Mikkola, H, Muszbek, L., Laiho, E., Syrjälä, M., Hämäläinen, E., Haramura, G., Salmi, T., Palotie, A.: Molecular mechanism of a mild phenotype in coagulation factor XIII deficiency: a splicing mutation that permits partial correct splicing of FXIII A-subunit mRNA. Blood  89,  1279-1287  (1997)

Mikkola, H., Muszbek, L., Haramura, G., Hämäläinen, E, Jalanko, A, Palotie, A.: Molecular mechanism of mutations in factor XIII A-subunit deficiency: In vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins. Thromb. Haemost. 77, 1068-72 (1997)

Muszbek, L., Rácz, É., Laposata, M.: Posttranslational modification of proteins with fatty acids in platelets. Prostaglandins, Leukotrienes and Essential Fatty Acids 57, 4/5 359-366 (1997)

Kappelmayer, J., Ajzner, É., Muszbek, L.: Incompatibility of a recombinant thromboplastin and an APTT reagent on a fully automated coagulation analyzer. Blood Coag. Fibrinol. 8, 251-252 (1997)

Szondy, Zs., Reichert, U., Bernardon, J.M., Michel, S., Tóth, R., Ancian, P., Ajzner, É., Fésüs, L.: Induction of apoptosis by retinoid acid receptor gamma-selective compunds in mouse thymocytes through a novel apoptosis pathway. Mol. Pharmacol. 51(6), 972-82 (1997)

Póka, R., Ajzner, É., Balogh, I.: Public health approach to activated protein C resistance assay. Am. J. Obst. Gynecol. 177(5), 1271-1272 (1997)

Gunda, T.E., Szőke, G.N.: Regiospecific bromination of cephalosporin sulfones at C-2 with cyanogen bromide. Synthetic Communication 27(19) 3395-3403 (1997)

Góth, L.: Further genetic heterogeneity in acatalasemia. Electrophoresis 18, 1942-1943 (1997)

Góth, L., Vitai, M.: Polymorphism of 5’ of the catalase gene in Hungrian acatalasmeia and hypocatalasemia. Electrophoresis 18, 1105-1108 (1997)

Góth, L., Vitai, M.: Reference ranges of normal blood catalase activity and levels in familial hypocatalasemia in Hungary. Clin. Chim. Acta 261, 35-42 (1997)

Udvardy, M., Pósán, E., Palatka, K., Altorjay, I., Hársfalvi, J.: Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis. Thromb. Res. 87, 75-82 (1997)

Azerad, M.A., Hársfalvi, J., Deckmyn, H., Vermylen, J., Michaux, J.L., Hoylaerts, M.F.: Recirculated normal platelets adhere to surfaces coated with plasma from patients with immune thrombocytopenia. Blood Coag. Fibrinol. 8, 59-64 (1997)



Újhelyi, L., Balla, J., Muszbek, L., Kakuk, G., Belcher, J., Jacob, H.S., Vercellotti, G.M., Balla, G.: A microassay to assess the oxidative resistance of low-density lipoproteins. Clin. Chem. 44, 1762-1764 (1998)

Kocsis, A., Biró, É., Rácz, É., Kiss, A., Kappelmayer, J.: Mean corpuscular volume is not a reliable marker of red cell age in case of anisocytosis. Ann. Hematol. 77, 149-151 (1998)

Szondy, Zs., Reichert, U., Bernardon, J.M., Michel, S., Tóth, R., Karászi, É., Fésüs, L.: Inhibition of activation-induced apoptosis of thymocytes by all-trans and 9-cis retinoic acids is mediated via retinoic acid receptor alpha. Biochem. J. 331, 767-774 (1998)

Góth, L.: Genetic heterogeneity of the 5’ uncoding region of the catalase gene in Hungarian acatalasemic and hypocatalasemic subjects. Clin. Chim. Acta 271, 73-78 (1998)

Kappelmayer, J., Bereczki, D., Misz, M., Oláh, L., Fekete, I., Csiba, L., Blaskó, Gy.: Monocytes express tissue factor in young patients with cerebral ischemia. Cerebrovasc. Dis. 8, 235-239 (1998)

Szűcs, S., Vámosi, Gy., Póka, R., Sárváry, A., Bárdos, H., Balázs, M., Kappelmayer, J., Tóth, L., Szöllősi, J., Ádány, R.: Single-cell measurement of superoxide anion and hydrogen peroxide production by human neutrophils with digital imaging fluorescence microscopy. Cytometry 33, 19-31 (1998)

Pósán, E., Hársfalvi, J., Szepesi, K., Gáspár, L., Batár, P., Udvardy, M.: Increased platelet activation and decreased fibrinolysis in the pathogenesis of aseptic necrosis of the femoral head. Platelets 9, 233-235 (1998)



Balogh, I., Póka, R., Pfliegler, Gy., Dékány, M., Boda, Z., Muszbek, L.: High prevalence of factor V Leiden mutation and 20210 A prothrombin variant in Hungary. Thromb. Haemos. 81: 660-661 (1999)

Muszbek, L., Yee, V.C., Hevessy, Zs.: Blood coagulation factor XIII: sturcture and function. Thromb. Res. 94: 271-305 (1999)

Muszbek, L., Haramura, G., Cluette-Brown J.E., Van Cott, E.M., Laposata, M.: The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids. Lipids  34: 331-7 (1999)

Balogh, I., Póka, R., Losonczy, G., Muszbek, L.: High frequency of factor V Leiden mutation and prothrombin 20210 A variant in Romanies of Eastern Hungary. Thromb. Haemost.   82: 1555-6 (1999)

Kerényi, A., Schlammadinger, Á., Ajzner, É., Szegedi, I., Kiss, Cs., Pap, Z., Boda, Z., Muszbek, L.: Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function Thromb. Res.  96: 487-492 (1999)

Szakony, Sz., Balogh, I., Muszbek, L.: The frequency of haemochromatosis C282Y mutation in the ethnic Hungarian and Romany population of Eastern Hungary. Br. J. Haemat. 107: 464-5 (1999)

Tornai I, Boda Z, Schlammadinger A, Juhasz A, Cauwenberghs N, Deckmyn H, Harsfalvi J. Acquired Bernard-Soulier syndrome: a case with necrotizing vasculitis and thrombosis. Haemostasis. 1999;29(4):229-236.

Fülesdi B, Limburg M, Berecki D, Káplár M, Molnár C, Kappelmayer J, Neuwirth G, Csiba L: Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. Journal of Diabetes and its Complications 13: 191-199, 1999



Katona, É., Haramura, G., Kárpáti, L., Fachet, J., Muszbek, L.: A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (a2b2Thromb. Haemost.  83: 268-73 (2000)

Wartiovaara, U., Mikkola, H., Szőke, G., Haramura, G., Kárpáti, L., Balogh, I., Lassila, R., Muszbek, L., Palotie, A.: Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb. Haemost.  84: 595-600 (2000)

Schlammadinger, Á., Kerényi, A., Muszbek, L., Boda, Z.,.: Comparison of the O’Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand’s disease. Thromb. Haemost. 84: 88-92(2000)

Hevessy, Zs., Patthy, A., Kárpáti, L., Muszbek, L.,: a2-plasmin inhibitor: a substrate for tissue transglutaminase. Thromb. Res. 99: 399-406 (2000)

Balogh, I., Szőke, G., Kárpáti, L., Wartiovaara, U., Katona, É., Komáromi, I., Haramura, G., Pfliegler, Gy., Mikkola, H., Muszbek, L.: Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 96: 2479-86 (2000)

Muszbek, L.: Deficiency causing mutations and common polymorphisms in the Factor XIII-A gene Thromb. Haemost. 84: 524-7 (2000)

Kárpáti, L., Penke, B., Katona, É., Balogh, I., Vámosi, Gy., Muszbek, L.: A modified, optimized kinetic photometric assay for he determination of blood coagulation factor XIII activity in plasma Clin. Chem. 46: 1946-55 (2000)

Cauwenberghs N, Meiring M, Vauterin S, van Wyk V, Lamprecht S, Roodt JP, Novak L, Harsfalvi J, Deckmyn H, Kotze HF.: Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1347-53.

Góth L.: Lipid and carbohydrate metabolism in acatalasemia. Clinical Chemistry. 2000;46:564-566

Góth L., Amir Shemirani, Tibor Kalmár: A novel catalase mutation ( a GA insertion) causes the Hungarian type of acatalasemia. Blood Cells, Molecules and Diseases. 2000;26:151-15

Góth  L., Gorzsás A., KalmárT.: A simple PCR-heteroduplex screening method for detection of a common mutation of the catalase gene. Clinical Chemistry. 2000;46:1199-1200.

Góth L., Eaton J.W.: Hereditary catalase deficiences and increased risk of diabetes.Lancet 2000;356:1820-1821.

V. Nagy E, Tóth J, Káldi I., Damjanovich J, Mezősi E, Lenkey Á, Tóth L, Szabó J, Karányi Zs. and Leövey A: Graves’ophthalmopathy: eye muscle involvement in patients with diploplia. European Journal of Endocrinology (2000) 142, 591-597

Káplár M, Kappelmayer J, Kiss A, Szabó K, Udvardy M: Increased Leukocyte-Platelet adhesion in chronic myeloproliferative disorders with high platelet counts. Platelets 11: 97-98, 2000

Regéczy N, Balogh I, Lakos G, Kappelmayer J, Kiss E: Membranous glomerulonephritis in a patient with inherited activated protein C resistance. Clinical Nephrology 53: 390-393, 2000

Kappelmayer J, Gratama J, Karászi É, Menéndez P, Ciudad J, Rivas R, Orfao A. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. Journal of Immunological Methods 242: 53-65, 2000



Ambrus, A., Banyai, I., Weiss M.S., Hilgenfeld, R., Keresztessy, Zs, Muszbek, L., Fésüs, L.: Calcium binding of transgutaminases: a 43Ca NMR study combined with surface polarity analysis J. Biomol. Struct. Dyn. 19: 59-74 (2001)

Katona, É., Ajzner, É., Tóth, K., Kárpáti, L., Muszbek, L.: Enzyme linked immunosorbent assay (ELISA) for he determination of blood coagulation factor XIII A-subunit in plasma and in cell lysate J. Immun. Meth. 258: 127-135 (2001)

Mátyus, L., Bene, L., Hársfalvi, J., Alvarez, M.V., González-Rodríguez, J., Jenei, A., Muszbek, L., Damjanovich S.: Organization of the glycoprotein (GP) IIb/IIIa heterodimer on resting human platelets studied by flow cytometric energy transfer J. Photochem. Photobiol. B: Biology 65: 47-58 (2001)

Sipka S, Szanto S, Szucs K, Kovacs I, Kiss E, Antal-Szalmas P, Lakos G, Aleksza M, Illes A, Gergely P, Szegedi G: Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus Journal of Rheumatology, 28., 2012-2017, 2001.

Sipka S, Szucs K, Szanto S, Kovacs I, Lakos G, Kiss E, Antal-Szalmas P, Szegedi G, Gergely P: Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 60., 380-384, 2001.

Antal-Szalmas P, I. Szöllősi, G. Lakos, E. Kiss, I. Csipo, A. Sümegi, S. Sipka, J.A.G. van Strijp, K.P.M. van Kessel, Gy. Szegedi: A novel flow cytometric assay to quantify soluble CD14 concentration in human serum. Cytometry, 45., 115-23, 2001.

Ulrichts H, Depraetere H, Harsfalvi J, Deckmyn H. Selection of phages that inhibit vWF interaction with collagen under both static and flow conditions. Thromb Haemost. 2001 Aug;86(2):630-5

Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalphareveals interaction between the leucine-rich repeat N-terminal and C-terminalflanking domains of glycoprotein Ibalpha. Blood. 2001 Aug 1;98(3):652-60.

Bonnefoy A, Harsfalvi J, Pfliegler G, Fauvel-Lafeve F, Legrand C.: The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI. Thromb Haemost. 2001 Mar;85(3):552-9.

Góth L., Rass P., Madarasi I.: A novel catalase mutation detected by PCR-SSCP, nucleotide sequencing and Western blot analyzes is responsible for the type C of  Hungarian acatalasemia. Electrophoresis 2001;22:49-51.

Góth L. A new type of inherited catalase deficiencies:Its characterization and comparison to  the Japanese and Swiss type of acatalasemia. Blood Cells, Molecules and Diseases 2001:24:512-517.

Góth L. Lenkey Á, Bigler NW. Blood catalase and diabetes in Hungary. Diabetes Care 2001, 10, 1839-40.

Góth L.  A novel catalase mutation (a G insertion in exon 2) causes the type B of the Hungarian acatalasemia. Clinica Chimica Acta 2001, 311, 161-3.

Karászi É, Jakab K, Homolya L, Szakács G, Holló Zs, Telek B, Kiss A, Rejtő, L, Nahajevszky S, Sarkadi B, Kappelmayer J. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. British Journal of Haematology 112: 308-314, 2001

Benkő I, Kovács P, Szegedi I, Megyeri A, Kiss A, Balogh E, Oláh É, Kappelmayer J, Kiss C. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. Naunyn-Schmiedeberg’s Archives of Pharmacology 363: 499-508, 2001

Oláh L, Misz M, Kappelmayer JAjzner É, Csépány T, Fekete I, Bereczki D, Csiba L.  Natural coagulation inhibitor proteins and elements of fibrinolytic system in young patients with cerebral ischemia. Cerebrovascular Diseases 12: 291-297, 2001

Kerekes L, Árkossy P, Altorjay I, Huszka M, Kappelmayer J, Tóth P, Szentkereszty Zs, Sápy P. Evaluation of the haemostatic changes and antioxidant capacity of blood in acute and chronic pancreatitis. Hepato-Gastroenterology  48: 1476-1479, 2001

Kappelmayer J, Kiss A, Karászi É, Veszprémi A, Jakó J, Kiss C. Identification of P-selectin Glycoprotein Ligand-1 as a useful marker in acute myeloid leukaemias. British Journal of Haematology 115:903-909, 2001

Káplár M, Kappelmayer J, Veszrémi A, Szabó K, Udvardy M. The role of in vivo formation of platelet-leukocyte aggregates in the pathogenesis of diabetic angiopathy. Platelets 12: 419-422, 2001



Ajzner, É., Balogh, I., Szabó, T., Marosi, A., Haramura, G., Muszbek, L.: Severe coagulation factor V deficiency caused by two novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene Blood 99: 702-5 (2002)

Sarvari, M., Kárpáti, L., Fésüs, L., Deli, L, Muszbek, L., Nemes, Z.: Competitive enzyme-linked immonosorbent assay for N( varepsilon )(gamma-glutamyl)lysine. Anal Biochem. 311(2): 187-90 (2002)

Soltész P, Aleksza M, Antal-Szalmás P , Lakos G, Szegedi Gy, Kiss E: Plasmapheresis modulates Th1/Th2 imbalance in patients with systemis lupus erythematosous according to measurement of intracytoplasmic cytokines. Autoimmunity. 35: 51-6 (2002)

Irinyi B, Aleksza M, Antal-Szalmás P , Sipka S, Hunyadi J, Szegedi A: Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria. Acta Dermatol Venereol. 82: 249-53 (2002)

Aleksza M, Lukacs A, Antal-Szalmas P , Hunyadi J, Szegedi A. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis. Brit J Dermatol. 147: 1135-41 (2002)

Bodolay E, Aleksza M, Antal-Szalmas P , Vegh J, Szodoray P, Soltesz P, Szegedi A, Szekanecz Z. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. J Rheumatol. 29: 2136-42 (2002)

Meiring MS, Litthauer D, Harsfalvi J , van Wyk V, Badenhorst PN, Kotze HF. In vitro effect of a thrombin inhibition peptide selected by phage display technology. Thromb Res. 107(6):365-71 (2002)

Dardik R, Shenkman B, Tamarin I, Eskaraev R, Harsfalvi J, Varon D, Inbal A: Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins Thromb Res. 105(4):317-23 (2002)

Novak L, Deckmyn H, Damjanovich S, Harsfalvi J: Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood. 99(6):2070-6 (2002)

Kappelmayer J, Karászi É , Telek B, Jakab K. “Pros and cons” on how to measure drug resistance in leukemias. Leuk Lymph 43: 711-717 (2002)

Jakab Z, Balogh E, Karászi E, Kappelmayer J , Kiss C, Olah E. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): Do outcomes differ from t (4, 11) Med Ped Oncol 39: 63-65 (2002)

K. Pető, A.V. Oláh , E. Bráth, I. Furka, I. Mikó: Relative antioxidant activity in relation with renal ischemia-reperfusion injury Eur. Surg. Res . 34 (suppl 1): 83 (2002)

Mikó I., Furka A., Ács G., Németh N., Sipka S., Oláh V.A ., Bráth E., Furka I.: Laboratory follow up of spleen autotransplants after experimantal spleen injuries. Eur. Surg. Res . (Suppl.) 189/34: 10-12 (2002)

Csáthy L., Oláh V.A ., Clemens B., György I. , Varga J.: Is there any tubular side effects of long-term antiepileptic treatment in children? J Salud (i) Ciencia (SIIC), (2002) (interneten elérhető)



Ajzner, E., Balogh, I., Haramura, G ., Boda, Z., Kalmár, K., Pfliegler, Gy., Dahlbäck, B., Muszbek, L.: Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J. Thromb. Hemost. 1: 943-9 (2003)

Inbal, A., Muszbek, L.: Coagulation factor deficiencies and pregnancy loss Semin. Thromb. Hemost. 29: 171-4 (2003)

Soltész, P., Veres, K., Lakos, G., Kiss, E., Muszbek, L., Szegedi, Gy.: Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus 12: 302-7 (2003)

Szegedi A, Aleksza M, Gonda A, Irinyi B, Sipka S, Hunyadi J, Antal-Szalmás P : Elevated rate of T helper 1 (T H 1) lymphocytes and serum IFN-gamma levels in psoriatic patients. Immunol Lett 86: 277-280 (2003)

Posan E, Szepesi K, .Gaspar L, Csernatony Z,. Harsfalvi J, Ajzner E, Toth A, Udvardy M. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head Blood Coag Fibrinolysis 14 (6):243-248 (2003)

Panyi, G., Bagdány, M., Bodnár, A, Vámosi, G, Szentesi, G, Jenei, A, Mátyus, L, Varga, S, Waldmann, T.A, Gáspár, R, Damjanovich, S.: Co-localization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc. Natl. Acad. Sci. 100: 2592-97 (2003)

Góth L . CK-2 antibody (Conan) recognises cancer associated ectopic form of CK-2. Clinica Chimica Acta329: 153-5 (2003)

Góth L , Vitai M. The effect of hydrogen peroxide generated by homocysteine and inherited catalase deficiency in human hypocatalasemic patients. Free Radicals Biol Dis 35: 882-888 (2003)

Magyar, MT., Szikszai Z, Balla J, Valikovics A, Kappelmayer J , Imre S, Balla G, Jeney V, Csiba L, Bereczki D. Early onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 34: 58-63, (2003)

Hrachovinova I, Cambien B, Hafezi Moghadam A, Kappelmayer J , Camphausen R, Widom A, Xia L, Kazazian HH, Schaub RG, McEver RP, Wagner DD. Pselectin/PSGL-1 interaction generates microparticles that correct hemostasis in a murine model of hemophilia. Nature Med 9: 1020-1025 (2003)

Szegedi É, Kiss I, Simon Á , Blaskó B, Reichert U, Michel S, Sándor M, Fésüs L, Szondy Zs. Ligation of Retionic Acid Receptor α Regulates Negative Selection of Thymocytes by Inhibiting Borh DNA Binding of nur 77 and Synthesis of Bim. The Journal of Immunology . 1, 170 (7), 3577-84, (2003)

Oláh V.A. , Ilyés I., Szőke A., Csízy I., Tóth J., Varga J.: Urinary homogentisic acid in alkaptonuric and healthy children. Clin Chem Lab Med 41/3: 356-359 (2003)



Jakó J, Szerafin L, Nagy P, Simon Á, Kappelmayer J . Familial malignant blood diseases. Lessons learned from a 20 year period. Leuk Lymph 45: 109-111 (2004)

Peyvandi F, Tagliabue L, Menegatti M, Karimi M, Komáromi I , Lak M, Muszbek L, Mannucci, PM.: Phenotype/Genotype characterisatin of 10 families with severe A subunit factor XIII deficiency. Hum Mutat 23: 98-107 (2004)

Bardi E, Bobok I, Olah AV , Olah E, Kappelmayer J, Kiss C. Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19(10):11457 (2004)

Kappelmayer J, Nagy B Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 42(5):475-86 (2004)

Kappelmayer J, Simon A, Kiss F, Hevessy Z . Progress in defining multidrug resistance in leukemia. Expert Rev Mol Diagn 4(2):209-17 (2004)

Nagy H, Goda K, Fenyvesi F, Bacso Z, Szilasi M, Kappelmayer J , Lustyik G, Cianfriglia M, Szabo G Jr. Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. Biochem Biophys Res Commun 315(4):942-9 (2004)

Antal-Szalmas P , Poppelier MJ, Sumegi A, van der Bruggen T, Verhoef J, van Kessel KP, van Strijp JA. Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. Immunol Lett 93(1):11-5 (2004)

Buban T, Schmidt M, Broll R, Antal-Szalmas P , Duchrow M. Detection of mutations in the cDNA of the proliferation marker Ki-67 protein in four tumor cell lines. Cancer Genet Cytogenet 149(1):81-4 (2004)

Szepesi K, Posan E, Harsfalvi J, Ajzner E , Szucs G, Gaspar L, Csernatony Z, Udvardy M. The most severe forms of Perthes’ disease associated with the homozygous Factor V Leiden mutation. J Bone Joint Surg Br 86(3):426-9 (2004)

Veres K, Lakos G, Kerenyi A , Szekanecz Z, Szegedi G, Shoenfeld Y, Soltesz P. Antiphospholipid antibodies in acute coronary syndrome. Lupus 13(6):423-7 (2004)

Inbal A, Muszbek L , Lubetsky A, Katona E , Levi I, Karpati L , Nagler A. Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation. Blood Coagul Fibrinolysis . 15(3):249-53 (2004)

Ulrichts H, Harsfalvi J , Bene L, Matko J, Vermylen J, Ajzenberg N, Baruch D, Deckmyn H, Tornai I. A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations. J Thromb Haemost . 2(9):1622-8 (2004)

Olah AV , Price RG, Csathy L, Orszagh E, Olah E, Varga J. Age dependence of serum beta-N-acetylhexosaminidase (NAG) activity. Clin Chem Lab Med . 42(3):305-6 (2004)

Toth T, Kupka S, Haack B, Riemann K, Braun S, Fazakas F , Zenner HP, Muszbek L , Blin N, Pfister M, Sziklai I. GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary. Hum Mutat 23(6):631-2 (2004)

Shemirani AH, Muszbek L . Rapid detection of the factor XIII Val34Leu (163 G>T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med 42(8):877-9 (2004)

Toth G, Schlammadinger J, Aradi J, Antal-Szalmas P , Sipka S, Balazs M, Kovacs P, Feher Z, Falus A . A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells. Cell Biol Int2004;28(11):817-23.

Szanto J, Andras C, Tsakiris J, Gomba S, Szentirmay Z, Banlaki S, Szilagyi I, Kiss C, Antall P , Horvath A, Lengyel L, Castiglione-Gertsch M. Secretory breast cancer in a 7.5-year old boy. Breast 13(5):439-42 (2004)

Bárdy E, Oláh AV, Bartyik K, Endreffy E, Jeney C, Kappelmayer J, Kiss C: Late effects of renal glomerular and tubular function in childhood cancer survivors. Pediatric Blood Cancer 43:668-673, (2004)



Aleksza M, Szegedi A, Antal-Szalmas P, Irinyi B, Gergely L, Ponyi A, Hunyadi J, Sipka S, Zeher M, Szegedi G, Danko K. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis. 64:1485-1489. (2005)

Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol. 25:1280-1286. (2005)

Goth L, Toth Z, Tarnai I, Berces M, Torok P, Bigler WN. Blood catalase activity in gestational diabetes is decreased but not associated with pregnancy complications. Clin Chem. 51:2401-2404. (2005)

Goth L, Vitai M, Rass P, Sukei E, Pay A. Detection of a novel familial catalase mutation (Hungarian type D) and the possible risk of inherited catalase deficiency for diabetes mellitus. Electrophoresis. 26:1646-1649. (2005)

Kappelmayer J, Simon A, Katona E, Szanto A, Nagy L, Kiss A, Kiss C, Muszbek L. Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost. 94:454-459. (2005)

Katona E, Nagy B, Kappelmayer J, Baktai G, Kovacs L, Marialigeti T, Dezso B, Muszbek L. Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation. J Thromb Haemost. 3:1407-1413. (2005)

Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerenyi A, Balogh I, Muszbek L. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Thromb Haemost. 93:904-909. (2005)

Pataki J, Szabo M, Lantos E, Szekvolgyi L, Molnar M, Hegedus E, Bacso Z, Kappelmayer J, Lustyik G, Szabo G. Biological microbeads for flow-cytometric immunoassays, enzyme titrations, and quantitative PCR. Cytometry A. 68:45-52. (2005)

Poka R, Vad S, Balogh I, Ajzner E. Variable effect of prothrombotic factors on fetomaternal circulation. Am J Obstet Gynecol. 193:2180-2181. (2005)

Sumegi A, Antal-Szalmas P, Aleksza M, Kovacs I, Sipka S, Zeher M, Kiss E, Szegedi G. Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosus. Clin Immunol. 117:271-279. (2005)

Hevessy Zs, Simon A, Kiss A, Nagy B Jr, Kiss F, Kappelmayer J. Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal noctural hemoglobinuria clones. Clin Chem Lab Med. 43:919-923. (2005)



Erdos M, Alapi K, Balogh I, Oroszlan G, Rakoczi E, Sumegi J, Marodi L. Severe Shwachman-Diamond syndrome phenotype caused by compound heterozygous missense mutations in the SBDS gene. Exp Hematol 34, 1517-1521, (2006)

Egyed B, Furedi S, Angyal M, Balogh I, Kalmar L, Padar Z. Analysis of the population heterogeneity in Hungary using fifteen forensically informative STR markers. Forensic Sci Int 158, 244-249, (2006)

Szekanecz E, András C, Sándor Z, Antal-Szalmás P, Szántó J, Tamási L, Kiss E, Szekanecz Z. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmunity Reviews 6, 42-47, (2006)

Ganacharya S, Bhattoa HP, Batár I. Premalignant and malignant cervical pathologies among non-medicated and copper containing intrauterine contraceptive device users: a 10-year follow-up study. Eur J Contracept Reprod Health Care 11(2), 89-97, (2006)

Katona K, Hercegh P, Kappelmayer J, Fésüs L, Aradi J. Deoxy-adenozin monophosphate (dAMP) dibutylester induces apoptosis by increasing the dATP level in HL-60 cells. Cancer Letters 235, 281-290, (2006)

Kiss F, Hevessy Zs, Veszpremi A, Katona E, Kiss C, Vereb G, Muszbek L, Kappelmayer, J. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost 96, 176-182, (2006).

Rőszer T, Kappelmayer J, Nagy GG, Szentmiklosi J, Basnakian A, Banfalvi G. The neuropeptide FMRFamide can protect cells against apoptosis in the snail digestive gland. Apoptosis 11, 173-182, (2006).

Ratei R, Karawajew L, Lacombe F, Jagoda K, Del Poeta G, Kraan J, De Santiago M, Kappelmayer J, Bjorklund E, Ludwig WD, Gratama J, Orfao A. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias. Cytometry Part B-Clinical Cytometry 70B. 1, 1-9, (2006)

Shemirani AH, Haramura G, Bagoly Z, Muszbek L. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma. Biochim Biophys Acta 1764, 1420-1423, (2006).

Szabo I, Kappelmayer J, Alekseev SI, Ziskin MC. Millimeter wave induced reversible externalization of phosphatidylserine molecules in cells exposed in vitro. Bioelectromagnetics 27, 233-244, (2006) .

Szarvas M, Oparaugo P, Udvardy ML, Toth J, Szanto T, Daroczi L, Vereb G, Harsfalvi J. Differential platelet deposition onto collagen in cone-and-plate and parallel plate flow chambers. Platelets 17, 185-190, (2006).

Szük T, Nagy B Jr, Bereczky Z, Köszegi Z, Édes I, Kappelmayer J. Effects of “ad hoc” clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets 17, 344-346, (2006).

Végh J, Szodoray P, Kappelmayer J, Csipő I, Udvardy M, Lakos G, Aleksza M, Soltész P, Szilágyi A, Zeher M. Szegedi G, Bodolay E. Clinical and immunological charactersitics of mixed connective tissue disease (MCTD) associated with pulmonary arterial hypertension. Scandinavian Journal of Immunology 64, 69-76, (2006).

Kiss E, Soltesz P, Der H, Kocsis Z, Tarr T, Bhattoa HP, Shoenfeld Y, Szegedi G. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmunity. 27(4),211-217,(2006)


Bene L, Kanyári Zs, Bodnár A, Kappelmayer J, Waldmann TA, Vámosi Gy, Damjanovich L. Colorectal carcinoma rearranges cell surface topology and density in CD4+ T cells. Biochem Biophys Research Communications 361, 202-207, 2007

Bárdi E, Bobok I, V Oláh A, Kappelmayer J, Kiss C. Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathology and Oncology Research. 13(3), 249-253, 2007

Der H, Kerekes G, Veres K, Szodoray P, Toth J, Lakos G, Szegedi G, Soltesz P. Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16(7), 497-503, 2007

Harangi, M., Mátyus, J., Nagy, E., Nagy, E., Paragh, Gy., Balla, J., V. Oláh A.: Identification of sulfhemoglobinemia after surgical polypectomy. Clinical Toxicology 45, 189-192, 2007

Kappelmayer J, Udvardy M, Antal-Szalmás P. Pgp and FLT3: identification and modulation of two proteins that lead to chemotherapy resistance in acute myeloid leukemia. Current Medicinal Chemistry 14, 519-530, 2007

Losonczy G, Rosenberg N, Boda Z, Vereb G, Kappelmayer J, Hauschner H, Bereczky Z, Muszbek L. Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica/The Hematology 92, 704-707, 2007

Nagy B Jr, Csongrádi É, Bhattoa HP, Balogh I , Blaskó G, Paragh G, Kappelmayer J, Káplár M. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thrombosis and Haemostasis 98, 186-191, 2007

Ratei R, McDonald A, Lacombe F, Karaevjew L, Jagoda K, Kappelmayer J, Orfao A, Bjorklund L, Gratama J. Discriminant Function Analysis as Decision Support System for the Diagnosis of Acute Leukemia with a Minimal Four Color Screening Panel and Multiparameter Flow Cytometry Immunophenotyping. Leukemia 92, 698-701, 2007

Sümegi A, Szegedi A, Gál M, Hunyadi J, Szegedi G, Antal-Szalmás P. Analysis of components of the CD14/TLR system on leukocytes of patients with atopic dermatitis. Int Arch Allergy Immunol.;143(3), 177-184, 2007

Szegedi I, Benko I, Mero G, Prinzinger A, Kappelmayer J, Kiss C. Long-lasting partial remission by Interferon-alpha treatment in a child with essential thrombocythemia. Pediatr Blood Cancer. 49, 744-747, 2007

Szekanecz E, Sándor Z, Antal-Szalmás P, Soós L, Lakos G, Besenyei T, Szentpétery A, Simkovics E, Szántó J, Kiss E, Koch AE, Szekanecz Z. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation? Ann N Y Acad Sci. 1108, 359-371, 2007

Takács L, Losonczy G, Matesz K, Balogh I, Sohajda Z, Tóth K, Fazakas F, Vereb G, Berta A. TGFBI (BIGH3) gene mutations in Hungary–report of the novel F547S mutation associated with polymorphic corneal amyloidosis. Mol Vis. 13, 1976-1983, 2007

Tarnai I, Csordás M, Sükei E, Shemirani AH, Káplár M, Góth L. Effect of C111T polymorphism in exon 9 of the catalase gene on blood catalase activity in different types of diabetes mellitus. Free Radic Res. 41(7), 806-811, 2007

Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, Kiss E. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center. Ann N Y Acad Sci. 1108, 76-82, 2007

Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 16(1), 39-45, 2007

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol. 32(2), 131-137, 2007

Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus 16(5), 324-328, 2007

Zsuga, J., Török, J., Magyar, M,T., Valikovics, A., Gesztelyi, R., Lenkey, Á., Csiba, L., Kéki, S., Zsuga, M., Bereczki, D.: Dimethylarginines at the crossroad of insulin resistance and atherosclerosis. Metabolism. 56, 394-399, 2007



Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35, 398-406, 2008.

Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss, C. Early relapse after rituximab chemoimmunotherapy. Pediatr Blood Cancer 50, 372-375, 2008.

Kiss F, Simon A, Csáthy L, Hevessy Z, Katona E, Kiss C, Kappelmayer J. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry73, 3, 194-201, 2008.

Miner JJ, Xia L, Yago T, Kappelmayer J, Liu Z, Klopocki AG, Shao B, McDaniel JM, Setiadi H, Schmidtke DW, McEver RP. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 112, 2035-2045, 2008.

Mohás M, Szigeti N, Markó L, Molnár GA, Cseh J, Laczy B, Tamaskó M, Balla J, Kappelmayer J, Wagner L, Wagner, Csiky B, Nagy J, Wittmann I. Serum total LDH activity and LDH-2 isozyme in nephrotic syndrome. Kidney Blood Press Res 31, 47-54, 2008.

Jiao H, Tóth B, Erdős M, Fransson I, Rákóczi E, Balogh I, Magyarics Z, Dérfalvi B, Csorba G, Szaflarska A, Megarbane A, Akatcherian C, Dbaibo G, Rajnavölgyi E, Hammarström L, Kere J, Lefranc G, Maródi L. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol 46(1):202-6, 2008.

Szekanecz E, Szűcs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun 31(4):372-6. 2008.

Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi Gy, Bodolay E. Vitamin D deficiency in Undifferentiated Connective Tissue Disease: a marker of progression into defined systemic autoimmune diseases. Arthritis Res Ther 10, R123, 2008.

Boda Z., Udvardy M., Rázsó K., Farkas K., Tóth J., Jámbor L., Oláh Z., Ilonczai P., Szarvas M., Kappelmayer J., Veréb Z., Rajnavölgyi E.: Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger’s Disease. Clin Appl Thromb Hemost 15(5):552-60, 2008.

A V Oláh, J. Mátyus, J. Kappelmayer, L. Újhelyi, J. Varga: Effect of creatinine methods on the eGFR: the new and old formulae. Hungarian Medical Journal Vol 2/1 (2008) 49-53.



McMurray J, Zerah S, Hallworth M, Koeller U, Blaton V, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O’Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Huisman W, Solnica B, Reguengo H, Grigore C, Spaňár J, Strakl G, Queralto J, Wallinder H, Schuff-Werner P. The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Code of Conduct, Version 2 – 2008. Clin Chem Lab Med (2009) 47:372-375

Toth JKappelmayer J, Udvardy ML, Szanto T, Szarvas M, Rejto L, Soltesz P, Udvrdy M, Harsfalvi J. Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythamia vera. Platelets (2009) 20 (4): 1-6

Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity (2009)42: 497-506

Szodoray P, Horvath FI, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B, Zeher M. The immune-regulatory role of vitamin A, D and E in patients with primary Sjögren’s syndrome. Rheumatology (2009)42: 497-506

Nagy B Jr, Bhavaraju K, Getz T, Bynagari YS, Kim S, Kunapuli SP. Impaired activation of platelets lacking protein kinase C-theta isoform. Blood (2009)113: 2557-2567

Chari R, Getz T, Nagy B Jr, Bhavaraju K, Mao Y, Bynagari YS, Swaminathan Murugappan, K Nakayama, Kunapuli SP. Protein kinase C delta differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol (2009) 29: 699-705

Bynagari YS, Nagy B Jr, Tuluc F, Bhavaraju K, Kim S, Vijayan VK, Kunapuli SP. Mechanism of activation and functional role of protein kinase C eta in human platelets. J Biol Chem (2009) 284: 13413-13421

Nagy B Jr, Simon Zs, Bagoly Zs, Muszbek L, Kappelmayer J. Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost (2009) 102: 83-89

Ajzner E, Schlammadinger Á, Kerényi A, Bereczky Zs, Katona É, Haramura G, Boda Z, Muszbek L. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood (2009) 113: 723-725

Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmás P, Agarwal A, Balla G, Balla J. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol (2009)20 (6): 1254-1263

Tanyi M, Olasz J, Lukács G, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, András C, Damjanovich L.
A new mutation in Muir-Torre syndrome associated with familiar transmission of different gastrointestinal adenocarcinomasEu J Surg Oncol  (2009) 35 (10): 1128-1130

Szekanecz Z, Aleksza M, Antal-Szalmás P, Soltész P, Veres K, Szántó S, Szabó Z, Végvári A, Szamosi S, Lakos G, Sipka S, Szegedi G, Varga J, Szücs G. Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects. Clin Rheumatol  (2009) 28 (3): 347-350



Mejstriková E, Fronkova E, Kalina T, Omelka M, Batinic D, Dubravic K, Pospisplova K, Vaskova M, Luria D, Stark B, Cheng A, Ng M, Leung Y, Kappelmayer J, Kiss F, Izraeli S, Schrappe M, Trka J, Stary J, Hrusak O. Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry. Ped Blood and Cancer (2010) 54 (1): 62-70

Nagy B Jr, Szűk T, Beke Debreceni IKappelmayer J. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets (2010)21(2): 147-151

P Szabó G, V. Oláh A, Kozak L, Balogh E, Nagy A, Blahakova I, Oláh É. A patient with Smith–Lemli–Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement. Eur J Pediatr  (2010) 169: 121–123

Lindqvist GP, Balogh I, Dahlback B. Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction. Acta Obstet Gynecol (2010) 89: 22-26

Bagoly Z, Fazakas F, Marosi A, Török O, Bereczky Z, Haramura G, Tóth J, Kappelmayer J, Muszbek L. Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin. Thromb Res (2010)125 (5): 427-431

McMurray J, Zerah S, Hallworth M, Koeller U, Blaton V, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O’Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Huisman W, Solnica B, Reguengo H, Grigore C, Spanár J, Strakl G, Queralto J, Wallinder H, Schuff-Werner P. The European Register of specialists in clinical chemistry and laboratory medicine: code of conduct Version 2-2008. Ann Biol Clin (Paris) (2010) 68 (1): 121-125

McMurray J, Zérah S, Hallworth M, Schuff-Werner P, Haushofer A, Szekeres T, Wallemacq P, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O’Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Jansen R, Solnica B, Reguengo H, Grigore C, Spaňár J, Strakl G, Queralto J, Wallinder H, Wieringa G. The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Guide to the Register, Version 3-2010. Clin Chem Lab Med (2010) 48 (7): 999-1008

Bardi E, Dobos E, Kappelmayer J, Kiss C. Differential Effect of Corticosteroids on Serum Cystatin C in Thrombocytopenic Purpura and Leukemia. Pathol Oncol Res (2010) 16 (3): 453-456

Hallay J, Oláh AV, Fülesdi B, Kocsor M, Végh T, Kovács G, Takács I, Sápy P, Nagy D, Telessy IG. Comparison of the effect of different lipid therapy as part of total parenteral nutrition on short term hepatobiliary response in patients underwent gastrointestinal surgery. Hepato-Gastroenter (2010) 57: 1069-1073



Vida A, Troelstra A, Antal-Szalmás P, Toon JP van Bommel, Andre´ Verheul FM, Jan Verhoef, Kok PM van Kessel, Jos AG van Strijp. Neutralization of Neisseria meningitidis outer membrane vesicles.  Inflamm Res (2011) 60: 801–805

Lakatos PL, Kiss SL, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M. Serum Lipopolysaccharide-binding Protein and Soluble CD14 are Markers of Disease Activity in Patients with Crohn’s Disease.  Inflamm Bowel Dis (2011) 17:767–777

Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, Hajas A, Sipka S, Gyimesi E, Gaal J, Barta Zs, Hallay J, Szegedi Gy, Bodolay E. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimm Rev (2011) 10: 155–162

Ivady GMadar LNagy B Jr., Gonczi F, Ajzner E, Dzsudzsak E, Dvořáková L, Gombos EKappelmayer J, Macek M Jr., Balogh I. Distribution of CFTR mutations in Eastern Hungarians: Relevance to genetic testing and to the introduction of newborn screening for cystic fibrosis. J Cyst Fibros (2011) 10: 217-220

Csongrádi E, Nagy B Jr, Fülöp T, Varga Zs, Karányi Zs, Magyar MT, Oláh L, Papp M, Facskó A, Kappelmayer J, Paragh Gy, Káplár M. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost (2011) 106 (4): 683-92

Miszti-Blasius KBeke Debreceni I, Felszeghy Sz, Dezső B, Kappelmayer J. Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge. Thromb Res (2011) 127: 228–234

Csáthy L, Kappelmayer J, Szegedi I, Kajtár B, Kiss Cs, Hevessy Zs. Classical and Atypical Neuroblastoma — Case Reports. Cytometry Part B (Clin Cytometr) (2011) 80B:134–136

Török O, Tóth B, Erdős M, Csorba G, Gyimesi E, Balogh I, Tóth Z, Maródi L. Molecular diagnostic challenges and complex management of consecutive twin pregnancies in a family with CD40 ligand deficiency. Scand J Immunology (2011) 75: 227-230

Losonczy G, Fekete Á, Vokó Z, Takács L, Káldi I, Ajzner É, Kasza M, Vajas A, Berta A, Balogh IAnalysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients. Acta Ophtha (2011) 89: 255–262

Imre L, Balogh I, Kappelmayer J, Szabó M, Melegh B, Wanker E, Szabó G. Detection of Mutations by Flow Cytometric Melting Point Analysis of PCR Products. Cytometry Part A (2011) 79A: 720-726

Kerekes Gy, Soltész P, Szűcs G, Szamosi Sz, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi Gy, Szekanecz Z. Effects of Adalimumab Treatment on Vascular Disease Associated with Early Rheumatoid Arthritis. IMAJ (2011) 13: 147-152

Oláh AV, Asztalos L, Ivády G, Varga É, Kovács ÁMKappelmayer J,  Varga J. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy. Clin Chem Lab Med (2011) 49: 1849-1853

Nagy B Jr, Jin J, Ashby B, Reilly M, Kunapuli SP. Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J Thromb Haemos (2011) 4: 810–819

Hajas Á, Sándor J, Csáthy L, Csípő I, Baráth S, Paragh Gy, Seres I, Szegedi Gy, Shoenfeld Y, Bodolay E. Vitamin D insufficiency in a large MCTD population. Autoimm Rev (2011) 10: 317–324

Ramya C, Yamini SB, Nagy B Jr, Kunapuli SP. Protein kinase C isoforms – implications to thrombosis. Curr Signal Transduct Ther (2011) 6: 353-362

Hevessy Zs, Hudák R, Kiss-Sziráki V, Antal-Szalmás P, Udvardy M, Rejtő L, Szerafin L, Kappelmayer J. Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay. Clin Chem Lab Med (2011) 50 (4): 689-92

Losonczy G, Fekete A, Voko Z, Takacs L, Kaldi I, Ajzner E, Kasza M, Vajas A, Berta A, Balogh I.
Analysis of complement factorH Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibilit to age-related macular degeneration in Hungarian Patients. Acta Ophthalmol (2011) 89 (3): 255-262

Bubán T, Koczok K, Földesi R, Szabó G, Sümegi A, Tanyi M, Szerafin L, Udvardy M, Kappelmayer J, Antal-Szalmás P. Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods. Clin Chem Lab Med. 2011 Nov 4;50(2):301-10. doi: 10.1515/CCLM.2011.762. PubMed PMID: 22053959.



Szegedi Gy, Csáthy L, Hevessy Zs, Kappelmayer J, Kiss Cs. Prognostic role of blood coagulation factor XIIIA expression in acute lymphoblastic leukemia. Hematol (2012) 97: 483-487

Bhattoa HP, Nagy E, More C, Kappelmayer J, Balogh A, Kalina E, Antal-Szalmas P. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study. Osteopor Inter (2012) 24(1): 179-86

Nagy B Jr, Miszti-Blasius K, Kerényi A, Clemetson KJ, Kappelmayer J. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation. Curr Med Chem (2012) 19 (4): 518-531

Simon Á, Bagoly Z, Hevessy Z, Csáthy L, Katona É, Vereb Gy, Ujfalusi A, Szerafin L, Muszbek L, Kappelmayer JExpression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry. Part B. Clin Cytomet (2012) 82B (4): 209-216

Papp M, Vitalis Zs, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Inter (2012) 32 (4): 603-611

Olah Zs, Kerenyi A, Kappelmayer J, Schlammadinger A, Razso K, Boda Z. Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure. Platelets (2012) 23 (6): 495-498

Shemirani Amir H, Nagy B Jr, Takáts A, Zsóri Katalin Sz., András Cs, Kappelmayer J, Csiki Z. Increased mean platelet volume in primary Raynaud’s phenomenon.  Platelets (2012) 23 (4): 312-316

Herczeg M, Lázár L, Bereczky Zs, Kövér Katalin E, Timári I, Kappelmayer J, Lipták A, Antus S, Borbás A. Synthesis and Anticoagulant Activity of Bioisosteric Sulfonic-Acid Analogues of the Antithrombin-Binding Pentasaccharide Domain of Heparin. Chemistry-A Eur J (2012) 18 (34): 10643-10652

Vida A, Bardoel B, Milder F, Majoros L, Sümegi A, Bácsi A, Vereb Gy, Kok PM Kessel, Jos AG Strijp, Antal-Szalmás P. Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils. Imm Letters  (2012) 146 (1-2): 31-39

Tanyi M, Olasz J, Tanyi Janos L, Tóth L, Antal-Szalmás P, Bubán T, András Cs, Urbancsek H, Garami Z, Csuka O, Damjanovich L. Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families. Familial Cancer (2012) 11(3): 519-524

Oláh AV, Fodor B, Mátyus J. Current questions on proteinuria and albuminuria. J Clin Metab Diabet (2012) 3 (1): 26-32

Török O, Tóth B, Erdős M, Csorba G, Gyimesi E, Balogh I., Tóth Z, Maródi L Molecular diagnostic challenges and complex management of consecutive twin pregnancies in a family with CD40 ligand deficiency. Scand J Imm (2012) 75 (2): 227-230

Nagy B Jr, Krasznai ZT, Balla H, Csobán M, Antal-Szalmás P, Hernádi Z, Kappelmayer JElevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem (2012) 49:377-80

Füzi M, Palicz Z, Vincze J, Cseri J, Szombathy Z, Kovács I, Oláh A, Szentesi P, Kertai P, Paragh G, Csernoch L. Fluvastatin-induced alterations of skeletal muscle function in hypercholesterolaemic rats.  J Muscle Res Cell Motil (2012) 32 (6): 391-401

Balogh I, Koczok K, Szabó GP, Török O, Hadzsiev K, Csábi G, Balogh L, Dzsudzsák E, Ajzner É, Szabó L, Csákváry V, Oláh AV. Mutational spectrum of Smith-Lemli-Opitz syndrome patients in Hungary. Mol Syndromol (2012) 3: 215-222

Gaal Z, Klupa T, Kantor I, Mlynarski W, Albert L, Tolloczko J, Balogh I, Czajkowski K, Malecki MT.
Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases. Diabetes Care. 2012, 35: e40

Losonczy G, Vajas A, Takacs L, Dzsudzsak E, Fekete A, Marhoffer E, Kardos L, Ajzner E, Hurtado B, de Frutos PG, Berta A, Balogh I. Effect of the Gas6 c.834+7G>A polymorphism and the interaction of known risk factors on AMD pathogenesis in Hungarian patients. PLoS One. 2012, 7: e50181

Nemeth N, Kiss F, Magyar Z, Miszti-Blasius K, Furka I: Following-up hemorheological consequences of gonadectomy in male and female rats. Clin Hemor Microcirc. 2012, 50(4): 231-243

Kotan R, Nemeth N, Kiss F, Posan J, Miszti-Blasius K, Toth L, Furka I, Miko I, Sapy P, Szentkereszty Z. Micro-rheological changes during experimental acute pancreatitis in the rat. Clin Hemor Microcirc. 2012, 51(4): 255-264

Shemirani AH, Nagy B, Takáts AT, Zsóri KS, András C, Kappelmayer J, Csiki Z. Increased mean platelet volume in primary Raynaud’ phenomenon. Platelets (2012) 23(4): 312-316

Wieringa G, Zerah S, Jansen R, Simundic AM, Queralto J, Solnica B, Gruson D, Tomberg K, Riittinen L, Baum H, Brochet JP, Buhagiar G, Charilaou C, Grigore C, Johnsen AH, Kappelmayer J, Majkic-Singh N, Nubile G, O’Mullane J, Opp M, Pupure S, Racek J, Reguengo H, Rizos D, Rogic D, Špaňár J, Štrakl G, Szekeres T, Tzatchev K, Vitkus D, Wallemacq P, Wallinder H. European Communities Confederation of Clinical Chemistry. The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine: version 4-2012. Clin Chem Lab Med (2012) 50(8): 1317-1328

Mokánszki A, Körhegyi I, Szabó N, Bereg E, Gergev G, Balogh E, Bessenyei B, Sümegi A, Morris-Rosendahl DJ, Sztriha L, Oláh E. Lissencephaly and band heterotopia: LIS1, TUBA1A, and DCX mutations in Hungary. J Neurology (2012) Dec; 27(12):1534-40

Németh N, Kiss F, Magyar Zs, Miszti-Blasius K, Furka I. Following-up hemorheological consequences of gonadectomy in male and female rats. Clin Hemorheol Microcir (2012) 50:(4) 231-243

Goth L, Nagy, Kosa Zs, Fejes Zs, Bhattoa HP, Paragh Gy, Kaplar M. Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus. Free Rad. Res. (2012) 46:(10) 1249-1257



Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmás P, Clemetson KJ, Nagy B Jr. Distinct effects of Re- and S-forms of LPS on modulating platelet activation. J Throm Haemos (2013) 11(4): 775-778

Antal-Szalmás P, Nagy B Jr, Debreceni IB, Kappelmayer J. Measurement of Soluble Biomarkers by Flow Cytometry. EJIFCC. 2013 Jan 16;23(4):135-42

Reményi G, Szász R, Debreceni IB, Szarvas M, Batár P, Nagy B Jr, Kappelmayer J, Udvardy M. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets (2013) 24(6): 486-492

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Laszlo Lakatos P, Kappelmayer J, Antal-Szalmás P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepat (2013) 59(3): 457-466

Oláh Zs, Szarvas M, Bereczky Zs, Kerenyi A, Kappelmayer J, Boda Z. Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Arch Pathol Lab Med, 2013;137(7):967-973.

Bagoly Z, Sarkady F, Magyar T, Kappelmayer J, Pongrácz E, Csiba L, Muszbek L. Comparison of a New P2Y12 Receptor 1 Specific Platelet Aggregation Test with 2 Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy. PLOS one (2013) 8(7): e69417

Bhattoa HP, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P, Kaplar M. Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheuma (2013) Aug; 32(8): 1161-7

Bhattoa HP, Wamwaki J, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P. Serum sclerostin levels in healthy men over 50 years of age. J Bone Min Metabol (2013) Sep; 31(5): 579-84

Palicz Z, Jenes A, Gáll T, Miszti-Blasius K, Kollár S, Kovács I, Emri M, Márián T, Leiter E, Pócsi I, Csősz E, Kalló G, Hegedűs C, Virág L, Csernoch L, Szentesi P. In vivo application of a small molecular weight antifungal protein of Penicillium chrysogenum (PAF). Toxic App Pharmacol (2013) May 15; 269(1): 8-16

Olah AV, Szabo GP, Varga J, Balogh L, Csabi G, Csakvary V, Erwa W, Balogh I. Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome. Eur J Pediat (2013) 172:(5) 623-630

Bedekovics J, Rejto L, Telek B, Kiss A, Hevessy Z, Ujfalusi A, Mehes G. Identification of NPMc+ acute myeloid leukemia in bone marrow smears. App Immhistchem Mol Morph (2013) 21:(1) 73-78

Olah Z, Szarvas M, Bereczky Z, Kerenyi A, Kappelmayer J, Boda Z. Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Arch Pathol (2013) 137:(7) 967-973

Kovacs B, Bereczky Z, Olah Z, Gindele R, Kerenyi A, Selmeczi A, Boda Z, Muszbek L. The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency. Ame J Clin Pathol (2013) 140:(5) 675-679

Timar O, Szekanecz Z, Kerekes G, Vegh J, Olah AV, Nagy G, Csiki Z, Danko K, Szamosi S, Nemeth A, Soltesz P, Szucs G. Rosuvastatin improves impaired endothelial function, lowers high sensitivity C-reactive protein, complement and immuncomplex production in patients with systemic sclerosis: a prospective case-series study. Arth Res Therapy (2013) 15:(5) R105

Gaál K, Lorincz H, Seres I, Harangi M, Oláh AV, Paragh G. Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions. Clin Biochem (2013) 46:(9) 825-827

Goldstein SR, Bhattoa HP, Neven P, Cox DA, Dowsett SA, Alam J, Sipos A, Muram D. Gynecological effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause J N Am Menop Soc (2012) 19:(1) 41-47

Miszti-Blasius K, Felszeghy S, Kiss C, Benkő I, Géresi K, Megyeri A, Hevessy Z, Kappelmayer J. P-selectin glycoprotein ligand-1 deficiency augments G-CSF induced myeloid cell mobilization. Naun Schmied Arch Pharmacol (2014) Feb; 387(2):109-18

Bessenyei B, Nagy A, Balogh E, Novák L, Bognár I, Knegt AC, Oláh E Achondroplasia with multiple suture craniosynostosis: a report of a new case of this rare association. Am J Med Genet. (2013) Oct, 161A(10):2641-2644.

Kovács B, Bereczky Z, Oláh Z, Gindele R, Kerényi A, Selmeczi A, Boda Z, Muszbek L. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Am J Clin Pathol. 2013 Nov;140(5):675-9.



Molnár Zs, Mokánszki A, Bazsáné KassaiZs, Bhattoa Harjit P, Benyó M, Oláh É, Jakab A. Sperm concentration, hyaluronic acid-binding capacity, aneuploidy and persistent histones in testicular cancer. Human Reproducion 29(9): pp. 1866-1874. (2014)

Molnár Z, Berta E, Benyó M, Póka R, Bazsáné Kassai Zs, Flaskó T, Jakab A, Bodor M. Fertility of testicular cancer patients after anticancer treatment: Experience of 11 years. Pharmazie 69: pp. 437-441. (2014)

Mokánszki A, Tóthné E V, Bodnár B, Tándor Z, Molnár Z, Jakab A, Ujfalusi A, Oláh É. In sperm hyaluronic acid binding ability predictive for clinical success of intracytoplasmic sperm injection: PICSI vs. ICSI? Systems Biology In Reproductive Medicine: Paper 10.3109/19396368.2014.948102. (2014)

Benyó M, Harsfalvi J, Pfliegler G, Molnár Z, Muranyi M, Józsa T, Flaskó T. Present Practice of Thrombosis Prophylaxis of Radical Prostatectomy in a European Country: A Hungarian Multicenter Study. Urologia Internationalis 92:(3) pp. 289-293. (2014)

Padra JT, Seres I, Oláh A, Fenyvesi F, ParaghJr.G, Csernoch L, Fórish G, Kertai P. A comparative study on dyslipidemia inducing diets in varios rat strains. Acta Physiologica Hungarica (2014) 101/2;250-258. (doi:10.1556/Aphysiol.101.2014.2.13) If: 0,747

Kovács B, Bereczky Zs, Selmeczi A, Gindele R, Oláh Z, Kerényi A, Boda Z, Muszbek L. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies. ClinChem Lab Med (2014) 52(12): 1797-1806

Mócsai G, Gáspár K, Nagy G, Irinyi B, Kapitány A, Bíró T, Gyimesi E, Tóth B, Maródi L, Szegedi A. Severe skin inflammation and fillagrin mutation similarly alter skin barrier in atopic dermatitis patients. Br.J.Dermatol. 170: 617-624 (2014) If: 3,759 (2012)

Nagy G, Minh D, Gáspár K, Mócsai G, Kapitány A, Töröcsik D, Bacsó Zs, Gyimesi E, Remenyik É, Bíró T, Szegedi A. The atopicskin-like microenvironment modulates the T cell-polarising cytokine production of myeloid DCs, as determined by laser scanning cytometry (Letter to the Editors) Exp. Dermatol. 23: 276-278 (2014) If: 3,578 (2012)

Gulácsy V, Soltész B, Petrescu C, Bataneant MM, Gyimesi E, Serban M, Maródi L, Tóth B. A novel large deletion and single nucleotide insertion in the Wiskott-Aldrich syndrome protein gene. Eur. J. Hematol. DOI: 10.1111/ehj.12424, 2014 If:2,414 (2013)

Tóth B, Soltész B, Gyimesi E, Csorba G, Veres A, Lányi A, Kovács G, Maródi L, Erdős M. Severe XLP phenotype caused by a novel intronic mutation in the SH2D1A gene. J.Clin.Immunol. 2014. PMID: 25491288 If: 2,654 (2013)

Szánthó E, Bhattoa HP, Csobán M, Antal- Szalmás P, Ujfalusi A, Kappelmayer J, HevessyZs. Serum thymdine kinase activity: Analytical Performance, age-related reference ranges and validation in chroniclymphocytic leukemia. Plos One 9:(3) p. e91647. (2014)

Bessenyei B, Tihanyi M, Hartwig M, Szakszon K, Oláh E. Variable expressivity of Pfeiffer syndrome in a family with FGFR1 p.Pro252Arg mutation. Am J Med Genet A, Dec; 164A(12):3176-3179.

Pludowski P, Grant W, Bhattoa HP, Bayer M, Povoroznyuk V, Rudenka E, Ramanau H, Varbiro S, Rudenka A, Karczmarewicz E, Lorenc RS, Czech-Kowalska J, Konstantynowicz J. Vitamin D status in Central Europe. Int J Endocrinol. (2014) Article ID 589587, 12 pages. (IF: 1.515)

Nagy B, Bhattoa HP, Steiber Z, Csobán M, Szilasi M, Méhes G, Müller M, Lázár J, Kappelmayer J, Antal-Szalmás P. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer. ClinChem Lab Med. (2014) 52(11):1639-48.doi: 10.1515/cclm-2014-0041.

Kalász J, PásztorTóth E, Bódi B, Fagyas M, Tóth A, Pal BH, G. Vári S, Balog M, Blažetić S, Heffer M, Papp Z, Borbély A. Single acute stress-induced progesterone and ovariectomy alter cardiomyocyte contractile function in female rats. CMJ (2014) 55: 239-49. (IF: 1.373)

Pósfai E, Irsai G, Illés A, Méhes G, Marton I, Molnár C, Csípő I, Baráth S, Gergely L. Evaluation of Significance of Lymphocyte Subpopulations and Non-specific Serologic Markers in B-cell Non-Hodgkin’s Lymphoma Patients. Pathol Oncol Res (2014) 3: 649-654

Bodolay E, Prohászka Z, Paragh G, Csipő I, Nagy G, Laczik R, Demeter N, Zöld E, Nakken B, Szegedi G, Szodoray P. Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease. Immunol Res. (2014) 60(1):50-9

Padra JT, Seres I, Oláh A, Fenyvesi F, Paragh Jr.G, Paragh G, Csernoch L, Fórish G,  Kertai P: A comparative study on dyslipidemia inducing diets in various rat strains, Acta Physiologica Hungarica (2014) 101/2;250-258.

Galamb D, Lenkey Á, Oláh A, Máth J, Márton I, Alberth M: Misure oggettive e soggettive per la valutazion della paura del dentista negli adolescenti: Studio pilota = Objective and subjective measurements for assessing dental fear in adolescents: A pilot study. Dent. Moderno (2014) 9, 88-98.

Tanyi M, Olasz J, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, Palatka K, András C, Urbancsek H, Garami Z, Csuka O, Damjanovich L. MLH1 and MSH2 mutation screening in HNPCC families of Hungary – Two new MMR gene mutations. Eur J Surg Oncol. 2014 Nov;40(11):1445-52. doi: 10.1016/j.ejso.2014.07.032.

Hunyadi J, András C, Szabó I, Szántó J, Szluha K, Sipka S, Kovács P, Kiss A, Szegedi G, Altorjay I, Sápy P, Antal-Szalmás P, Tóth L, Fazekas G, Rajnavölgyi É. Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study. Pathol Oncol Res. 2014 Apr;20(2):357-65. doi: 10.1007/s12253-013-9704-3

Galamb, D., Lenkey, Á., Oláh, A., Máth, J., Márton, I., Alberth, M. Misure oggettive e soggettive per la valutazion della paura del dentista negli adolescenti: Studio pilota = Objective and subjective measurements for assessing dental fear in adolescents: A pilot study. Dent. Moderno (2014) 9: 88-98.


Ivády G, Koczok K, Madar L, Gombos É, Tóth I, Győri K, Balogh I. Molecular analysis of cystic fibrosis patients in hungary – an update to the mutational spectrum. J Med Biochem. (2015) 34: 46–51.

Árokszállási A, Kerényi A, Katona É, Bereczky Z, Muszbek L, Boda Z, Schlammadinger Á. The use of recombinant factor XIII in a major bleeding episode of a patient with congenital FXIII deficiency – thr first experience. Haemophilia  (2015) 21.118-121.

Ilonczai P, Oláh Z, Selmeczi A, Kerényi A, Bereczky Z, Póka R, Schlammadinger Á, Boda Z. Management and outcome of pregnancies in women with antithrombin deficiency: a single center experience and review of literature. Blood Coagul Fibrinolysis (2015) 26(7):798-804.

Lőrincz H, Harangi M, Oláh AV, Szabó GP, Fülöp P, Somodi S, Paragh G, Seres I: Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome. Pediatric Research (2015) 77, 703-709.

Gáspár K, Baráth S, Nagy G, Mócsai G, Gyimesi E, Szodoray P, Irinyi B, Zeher M, Remenyik E, Szegedi A. Regulatory T-cell Subsets in Atopic Dermatitis: Important Indicators of Disease Severity with Acquired Functional Impairment. Acta Derm Venereol. (2015) 95: 151-155

Papp G, Horvath IF, Gyimesi E, Barath S, Vegh J, Szodoray P, Zeher M. The assesment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study. Immunol. Res. (2015) PMID: 26168768

E. Polonkai, E. Gyimesi,  I. Kovács,  A. Csillag,  Gy. Balla,  É. Rajnavölgyi, A. Bácsi, S. Sipka . A possible role of elevated breast milk lactoferrin and the cytokine IL-17 levels in predicting early allergy in infants: A pilot study  Acta Alimentaria (2015) DOI: 10.1556/AAlim.2015.0001

Mócsai G, Gáspár K, Dajnoki Z, Tóth B, Gyimesi E, Bíró T, Maródi L, Szegedi A. Investigation of skin barrier functions and allergic sensitization in patients with hyper-IgE syndrome.  J. Clin. Immunol. (2015)  35: 681-688

Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. J Crohns Colitis. (2015) Oct;9(10):891-8. doi: 10.1093/ecco-jcc/jjv127.

Kulcsar-Jakab E, Petho Z, Pap Z, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P, Bhattoa HP. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. BMC Musculoskelet Disord. (2015) Aug 28;16:227. doi: 10.1186/s12891-015-0684-1.

Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]. J Crohns Colitis. (2015) Aug;9(8):659-68. doi: 10.1093/ecco-jcc/jjv087.

Kappelmayer J, Antal-Szalmás P, Nagy B Jr. Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders. Clin Chim Acta. 2015 Jan 1;438:35-42. doi: 10.1016/j.cca.2014.07.040.

N. Sipeki, L. Davida, E. Palyu, I. Altorjai, J. Harsfalvi, P. Antal-Szalmas, Z. Szabo, G. Veres, Z. Shums, GL. Norman, PL. Lakos, M. Papp: Prevalence; significance and predictive value of antiphospholipid antibodies (APLA) in Crohn’s disease. World Journal of Gastroenterology (2015) 21:6952-6964.

Szántó A, Szabó K, Nagy G, Molnár C, Zeher M. Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren’s Syndrome. Pathol Oncol Res. (2016) Jan 19. [Epub ahead of print]

Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L. Factor XIII B subunit polymorphisms and the risk of coronary artery disease. Int J Mol Sci. (2015) Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143.

Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke. Blood Coagul Fibrinolysis. (2014) Jun;25(4):364-8. doi: 10.1097/MBC.0000000000000055.

Nagy T, Paszti E, Kaplar M, Bhattoa HP, Goth L. Further acatalasemia mutations in Hungarian patients with diabetes and microcytic anemia. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.(2015) 772:10–14. doi:10.1016/j.mrfmmm.2014.12.008

Petho Z, Kulcsar-Jakab E, Kalina E, Balogh A,Pusztai A, Gulyas K, Horvath A, Szekanecz Z, Bhattoa HP. Vitamin D status in men with psoriatic arthritis: a case-control study. OsteoporosisInt (2015) 26:1965–1970DOI 10.1007/s00198-015-3069-2

Kincse G, Bhattoa PH, Herédi E, Varga J, Szegedi A, Kéri J, Gaál J. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol (2015) May 11. doi: 10.1111/1346-8138.12876.

Karras SN, Annweiler C, Boucher B, Bhattoa HP, Muscogiuri G, Stefan P. Re: Bias, Bones and Vitamin D. Response to: Grey A, Bolland MJ. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ (2015) 351 doi:

Bodoki L, Chen JQ, Zeher M, Nagy-Vincze M, Griger Z, Zilahi E, Dankó K. Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy. Biomed Res Int. 2015:809895.

Horton DL, McElhinney LM, Freuling CM, Marston DA, Banyard AC, Goharrriz H, Wise E, Breed AC, Saturday G, Kolodziejek J, Zilahi E, Al-Kobaisi MF, Nowotny N, Mueller T, Fooks AR. Complex epidemiology of a zoonotic disease in a culturally diverse region: phylogeography of rabies virus in the Middle East. PLoS Negl Trop Dis. 2015 Mar 26;9(3)

Chen JQ, Zilahi E, Papp G, Sipka S, Zeher M. Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2015 Dec 1


Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown – pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol. 2016 Nov 7;22(41):9172-9185.

Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int. 2016 Nov;36(11):1628-1638. doi: 10.1111/liv.13133.

Nagy B Jr, Nagy B, Fila L, Clarke LA, Gönczy F, Bede O, Nagy D, Újhelyi R, Szabó Á, Anghelyi A, Major M, Bene Z, Fejes Z, Antal-Szalmás P, Bhattoa HP, Balla G, Kappelmayer J, Amaral MD, Macek M Jr, Balogh I. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis. Chest. 2016 Sep;150(3):661-72. doi: 10.1016/j.chest.2016.04.006.

Korade Z, Kim HY, Tallman KA, Liu W, Koczok K, Balogh I, Xu L, Mirnics K, Porter NA. The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts. Journal of  Medicinal Chemistry (2016) 59(3):1102-1115

Zádori D, Szpisjak L, Madar L, Varga VE, Csányi B, Bencsik K, Balogh I, Harangi M, Kereszty É, Vécsei L, Klivényi P. Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series. Neurol Sci (2016) Nov 25. [Epub ahead of print]

Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Setric J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One (2016) 11(9):e0162866

Balogh A, Bhattoa HP. Normális laboratóriumi értékek terhességben. [Reference ranges in pregnancy]. In A várandósgondozás kézikönyve [Handbook of pregnancy care]. Ed. Papp Z. Medicina könyvkiadó, Budapest 2016. pp. 123-130. ISBN: 978 963 226 566 7

Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, Cannell JJ, Foresta C, Grübler MR, Kotsa K, Mascitelli L, März W, Orio F, Pilz S, Tirabassi G, Colao A. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol 2016 Jul 18. [Epub ahead of print]

Csenteri OK, Sándor J, Kalina E, Bhattoa HP, Gődény S. The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome. Gynecol Endocrinol 2016 Jul 28:1-5. [Epub ahead of print]

Bombicz M, Priksz D, Varga B, Gesztelyi R, Kertesz A, Lengyel P, Balogh P, Csupor D, Hohmann J, Bhattoa HP, Haines DD, Juhasz B.. Anti-Atherogenic Properties Of Allium Ursinum Liophylizate: Impact On Lipoprotein Homeostasis And Cardiac Biomarkers Under Hypercholesterolemic Circumstances. Int J Mol Sci 2016 Aug 10;17(8). pii: E1284. doi: 10.3390/ijms17081284.

Becs G, Hudák R, Fejes Z, Debreceni IB, Bhattoa HP, Balla J, Kappelmayer J. Haemodiafiltration elicits less platelet activation compared to haemodialysis. BMC Nephrology 2016. Oct 13;17(1):147.

Juhasz B, Gulyás K, Horváth Á, Pethő Z, Bhattoa HP, Váncsa A, Szekanecz É, Horváth C, Kocsis J, Horváth Z, Hodosi K, Szántó S, Szűcs G, Szekanecz Z. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. Osteoporos Int 2016 Dec 10.

Bhattoa HP, Konstantynowicz J, Laszcz N, Wojcik M, Pludowski P. Vitamin D: Musculoskeletal health. Rev Endocr Metab Disord 2016 Dec 29. doi: 10.1007/s11154-016-9404-x.

Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, Balercia G, Kimball S, Kotsa K, Mascitelli L, Bhattoa HP, Colao A. Vitamin D and Cardiovascular Disease: from atherosclerosis to myocardial infarction and stroke. International Journal of Cardiology 2016 dec 26. Doi: 10.1016/j.ijcard.2016.12.053

Comment: Boucher B, Grant WB, Bhattoa HP. Exploring the role of Vitamin D.  Comments on Fleury et  al. Sun exposure and its effects on human health: mechanisms through which sun exposure could reduce the risk of developing obesity and cardiometabolic dysfunction. Int. J. Environ. Res. Public Health 2016, 13, 999. Int. J. Environ. Res. Public Health 2016, 13, 1256; doi:10.3390/ijerph13121256.

Eszter Szánthó, Bettina Kárai, Gergely Ivády, Judit Bedekovics, István Szegedi, Miklós Petrás, György Ujj, Anikó Ujfalusi, Csongor Kiss, János Kappelmayer, Zsuzsanna Hevessy. Comparative analysis of multicolour flow cytometry and immunohistochemistry for the detection of disseminated tumour cells. Appl Immunohistochem Mol Morphol, accepted for publication

Papp G, Horvath IF, Gyimesi E, Barath S, Vegh J, Szodoray P, Zeher M. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study. Immunol Res. 2016 Apr;64(2):404-11.

Vass M, Diószegi Á, Németh N, Sógor V, Baráth S, Szalai E, Módis L, Pál S. Rheopheresis in vascular diseases. Clin Hemorheol Microcirc. 2016 Oct 15. [Epub ahead of print]

Kerényi A, Debreceni IB, Oláh Z, Ilonczai P, Bereczky Z, Nagy B Jr, Muszbek L, Kappelmayer J. Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome. Cytometry B Clin Cytom. 2016 Feb 9.

Pénzes K, Rázsó K, Katona É, Kerényi A, Kun M, Muszbek L. Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome – characterization of the antibody. J Thromb Haemost. 2016;14(8):1517-20.

Mezei, Z. A., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism. Thromb. Res. 148, 101-106, 2016. DOI:

Fejes Z, Póliska S, Czimmerer Z, Káplár M, Penyige A, Gál Szabó G, Beke Debreceni I, Kunapuli SP, Kappelmayer J, Nagy B Jr. Hyperglycemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost. 2016 Dec 15. [Epub ahead of print]

Balogh E, Nagy B Jr, Gyetvai Á, Bene Z, Hendrik Z, Jeney V, Nagy P, Papp Á, Balla J, Balla G, Kappelmayer J, Nagy B. Impaired immunosuppressive effect of bronchoalveolar mesenchymal stem cells in hypersensitivity pneumonitis: Preliminary findings. Cytometry B Clin Cytom. 2016 Oct 28. doi: 10.1002/cyto.b.21490. [Epub ahead of print]

Kasza M, Meleg J, Vardai J, Nagy B Jr, Szalai E, Damjanovich J, Csutak A, Ujhelyi B, Nagy V. Plasma E-selectin levels can play a role in the development of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 Jul 4. [Epub ahead of print]

Balogh E, Tolnai E, Nagy B Jr, Nagy B, Balla G, Balla J, Jeney V. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta. 2016 Sep;1862(9):1640-9.

Szük T, Fejes Z, Debreceni IB, Kerényi A, Édes I, Kappelmayer J, Nagy B Jr. Integrity® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience® everolimus-eluting stents in stable angina patients. Platelets. 2016 Jul;27(5):410-9.

Gabor Papp*, Edit Gyimesi*, Krisztina Szabo, Éva Zöld and Margit Zeher. Increased IL-21 expression induces granzyme B in peripheral CD5+ B cells as a potential counter-regulatory effect in primary Sjögren’s syndrome. Mediators of Inflammation 2016:4328372.  doi: 10.1155/2016/4328372 *Both authors contributed equally to this work


B. Kárai, J. Bedekovics, Zs. Miltényi, L. Gergely, L. Szerafin, A. Ujfalusi, J. Kappelmayer, Zs. Hevessy. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes. Int J Lab Hematol 2017 DOI: 10.1111/ijlh.12700

B. Kárai*, Zs. Hevessy*, E. Szánthó, L. Csáthy, A. Ujfalusi, K. Gyurina, I. Szegedi, J. Kappelmayer, Cs. Kiss. Expression of coagulation factos XIII subunit A correlates with outcome in childhood acute lymphoblastic leukemia. Pathol Oncol Res 2017 DOI 10.1007/s12253-017-0236-0

Tóth CN, Baranyai E, Csípő I, Tarr T, Zeher M, Posta J, Fábián I. Elemental analysis of whole and protein separated blood serum of patients with systemic lupus erythematosus and Sjögren’s syndrome. Biol Trace Elem Res. 2017 Jan 26. doi: 10.1007/s12011-017-0945-y.